Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 232 is a genomic DNA sequence homologous to the functional 7SK small nuclear RNA gene but is classified as a pseudogene, meaning it does not encode a functional product and is not known to participate in any canonical biological processes[1]. The functional 7SK RNA plays a critical regulatory role in transcription by modulating the activity of the positive transcription elongation factor P-TEFb, specifically by sequestering its kinase activity and interacting with associated protein complexes[2][3]. Pseudogenes such as RN7SKP232 arise through genomic duplication or retrotransposition events, but they typically lack the regulatory sequences or structures required to produce functional RNA, and thus do not serve as therapeutic targets, receptors, enzymes, or other classical druggable biomolecules. RN7SKP232 is not a therapeutic target and does not encode a functional molecule. There is nothing inherently therapeutic or actionable about this pseudogene, nor any established biomarker, disease association, interacting drug, or safety concern linked specifically to RN7SKP232 or other RN7SK pseudogenes[1]. The functional gene 7SK (not this pseudogene) is a well-studied non-coding RNA, integrally involved in transcriptional regulation, especially in neuronal biology[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 232 (RN7SKP232).